4 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
in Pulmonary Arterial ... Hypertension (PAH ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Arterial Hypertension ... (PAH) Management ... Algorithm Dr. ... #PAH #Management ... #pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
ATRA treatment Pathophysiology ... myalgias, HoTN, edema ... Imaging: CXR- pulmonary ... APML #diagnosis #management ... #hematology #oncology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... amyloidosis, PAH ... Nephrogenic DI Hematologic ... lubricants • Pharmacologic ... #Diagnosis #Management